Fund shareholders of GALMED PHARMACEUTICALS LTD
ISIN IL0011313900 · Israel · LEI 549300FL07PJ8ICSMD04
- Fund shareholders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 946.3 $
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 1,701 | 946.3 $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 1 | -1 | 1,701 | -13.8 % |
| 2026Q2 | 2 | 0 | 1,973 | 0.0 % |
| 2026Q1 | 2 | +1 | 1,973 | +16.0 % |
| 2025Q4 | 1 | 0 | 1,701 | 0.0 % |
| 2025Q3 | 1 | 0 | 1,701 | 0.0 % |
| 2025Q2 | 1 | 0 | 1,701 | 0.0 % |
| 2025Q1 | 1 | -1 | 1,701 | -8.1 % |
| 2024Q4 | 2 | 0 | 1,851 | -91.7 % |
| 2024Q3 | 2 | 0 | 22,214 | +0.0 % |
| 2024Q2 | 2 | 0 | 22,214 | 0.0 % |
| 2024Q1 | 2 | 0 | 22,214 | 0.0 % |
| 2023Q4 | 2 | 22,214 |
Cite this page
Titelia. "Fund shareholders of GALMED PHARMACEUTICALS LTD". https://titelia.com/en/stocks/galmed-pharmaceuticals-ltd-IL0011313900